Il semble que vous utilisiez une version obsolète de internet explorer. Internet explorer n'est plus supporté par Microsoft depuis fin 2015. Nous vous invitons à utiliser un navigateur plus récent tel que Firefox, Google Chrome ou Microsoft Edge.
anwar D.Results with Sirolimus coated Drug balloons ??
Joindre des fichiers
Sélectionnez vos fichiers, cliquez sur le bouton envoyer, rédigez votre comentaire puis cliquez sur le bouton envoyer. (formats autorisés : images jpeg, gif, png, and PDF)
Your browser doesn't have Flash, Silverlight or HTML5 support.
Daniel W.Excellent question! The DCB technology with Sirolimus is emerging and many companies are active in this field, as BBRAUN, Mynvasis, Concept Medical, Orchestra Biomed. The data are scarce and conclusions preliminary. Seems to have the potential to be equal. Preliminarny clinical data are positive mainly for ISR, less for small vessels. SBut I think can be the choice of the future. As it is difficult to create a DCB with the hydrophilic Sirolimus, there can be differences between the sirolimus DCBs, as senn with the Pclitaxel DCBs. Hope that helps.
Joindre des fichiers
Sélectionnez vos fichiers, cliquez sur le bouton envoyer, rédigez votre comentaire puis cliquez sur le bouton envoyer. (formats autorisés : images jpeg, gif, png, and PDF)
Your browser doesn't have Flash, Silverlight or HTML5 support.
anwar D. Results with Sirolimus coated Drug balloons ??
Daniel W. Excellent question! The DCB technology with Sirolimus is emerging and many companies are active in this field, as BBRAUN, Mynvasis, Concept Medical, Orchestra Biomed. The data are scarce and conclusions preliminary. Seems to have the potential to be equal. Preliminarny clinical data are positive mainly for ISR, less for small vessels. SBut I think can be the choice of the future. As it is difficult to create a DCB with the hydrophilic Sirolimus, there can be differences between the sirolimus DCBs, as senn with the Pclitaxel DCBs. Hope that helps.